Contact

Pioneering Innovation

Our News

Amplity's new CEO Christina DiBiase
Read Now arrow
  • Press Release
  • Press Release

Amplity Names Christina DiBiase Chief Executive Officer

April 30, 2026

  • Company Updates
Filters

Filters

Type

News – Categories Filter Checkbox

Topic

News – Topics Filter Checkbox
  • Press Release
Read Article arrow

Amplity Showcases AI-Powered RWE Posters at ISPOR 2026

May 20, 2026
  • Research
Treatment of mNSCLC utilizes targeted therapy or chemotherapy and is often guided by molecular profiling.
Read Article arrow

Targeted Therapy Gap In EGFR+ mNSCLC

May 19, 2026
  • Press Release
A landing page for in practice an oncology intelligence platform, featuring subscription details and resources for community practice
Read Now arrow

Amplity Launches Next-Generation Media Platform For Community Oncologists

April 28, 2026
  • Article
Read Article arrow

How AI-Driven Pharma Decisions Can Expand Kidney Cancer Treatment Awareness

October 21, 2025
  • Research
Early TKI Disruptions In ROS1+ NSCLC Reveal Treatment Gaps
Explore Research arrow

Early TKI Disruptions In ROS1+ NSCLC Reveal Treatment Gaps 

May 21, 2025
  • Research
Lung cancer is a common and deadly cancer in the United States.
Explore Research arrow

Streamlining NSCLC Patient Identification

May 21, 2025
  • Press Release
JONS and Tigerlily Foundation Partnership.
Read Article arrow

JONS & Tigerlily Foundation Partner On Initiative

January 16, 2025
  • Article
Oncology nurse navigators help patients experience less stress and get access to timely care.
Read Article arrow

New Funding Spells Growth For Nurse Navigators

January 7, 2025
  • Article
Precision medicine (PM), or personalized medicine, brings new hope to patients with cancer, with treatments tailored to individual genetic profiles.
Read Article arrow

6 Challenges In Precision Medicine Launches

December 19, 2024
  • Article
Read Article arrow

The 60-Second Data Story, Simple, Clear, Confident

May 26, 2026
  • Press Release
Read Article arrow

Amplity Showcases AI-Powered RWE Posters at ISPOR 2026

May 20, 2026
  • Research
Real-world research on how severity drives resource burden in OI.
Read Article arrow

How Severity Drives Resource Burden In OI

May 20, 2026
  • Research
Treatment of mNSCLC utilizes targeted therapy or chemotherapy and is often guided by molecular profiling.
Read Article arrow

Targeted Therapy Gap In EGFR+ mNSCLC

May 19, 2026

Who You’ll Be Working With

Our Senior Leaders Are With You Every Step Of The Way →

Events and Webinars

  • Conference

Life Sciences Trainers & Educators Network (LTEN) Annual Conference I Orlando, FL

  • Jun 15, 2026
  • - Jun 18, 2026
  • Jun 15, 2026
  • - Jun 18, 2026

•

  • Conference
  • Webinar

How To Strengthen Launch Strategies With Medical-Commercial Collaboration

  • Jun 25, 2026
  • - Jun 25, 2026
  • Jun 25, 2026
  • - Jun 25, 2026

•

  • Webinar
Powerful Partnerships Start Here
Get in Touch